← All trials
NCT04820322
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 24, 2018
- Primary completion
- Oct 19, 2018
- Completion date
- Oct 19, 2018
- First posted
- Mar 29, 2021
- Last posted
- Mar 29, 2021
- Enrollment
- 16
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- MGP Ingredients, IncLead sponsor
- Glycemic Index Laboratories, IncReponsible party - principal investigator
- Glycemic Index Laboratories, IncOverall official - principal investigator
- Glycemic Index Laboratories, IncCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.